CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


We found 7125 result(s)


Published on: December 7, 2015
Result type: General Content

The CADTH Scientific Advice Program is a voluntary, fee-for-service consultation offered to pharmaceutical companies. Through this Program, CADTH offers advice on early drug development plans from a health technology assessment perspective. CADTH Scientific Advice is offered at an early point in the drug development process before development p...

Vagal Nerve Blockade for Obesity: VBLOC Therapy Using the Maestro RC2 Device

Last Updated: October 23, 2015
Result type: Reports
opens in document viewer

Alternative safe, effective, minimally invasive, and reversible weight-loss surgeries are needed to bring about sustained and clinically significant weight loss in patients for whom drug therapy or bariatric surgery are not indicated, or who do not want to undergo bariatric procedures that are invasive, irreversible, and bring a higher risk o...

  • Project Number: EH0031

Call for Topics for Medical Devices

Published on: October 28, 2015
Result type: News

CADTH invites interested individuals to propose topics for future CADTH Health Technology Assessment or Optimal Use projects. We are specifically seeking topics related to medical devices, diagnostic testing, and medical, dental, and surgical procedures or programs that require information for pan-Canadian practice, purchasing, or policy decisi...

Antihemophilic Factor (Recombinant BDD) Fc Fusion Protein (Eloctate): Treatment Cost Comparison and Budget Impact Analysis

Last Updated: November 9, 2015
Result type: Reports
Product Line: Technology Review

This report aims to: Assess the comparative cost of coagulation factor VIII (recombinant) Fc fusion protein (Eloctate) with recombinant antihemophilic factors (Kogenate FS, Xyntha, and Advate) in both control and prevention of bleeding episodes. Assess, from the Canadian health ministry perspective, the budgetary impact of reimbursing Elocta...

  • Project Number: OB0004

CADTH Lecture Series — Dr. Michael Burgess

Published on: November 17, 2015
Result type: News

The CADTH Lecture Series provides prominent scholars and opinion leaders with a forum to discuss pressing issues facing health technology assessment (HTA) and health care today. Join the CADTH Lecture Series for the last session before the holidays. The lecture, Is Deliberative Public Engagement Worth the Trouble?, will be hosted by D...

New at CADTH - November 2015

Published on: November 19, 2015
Result type: News

Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Health Technology Update — Issue 5

Last Updated: January 12, 2007
Result type: Reports
Product Line: Health Technology Update

As we launch into 2007, our fifth issue of Health Technology Update brings you information on several new health technologies for the diagnosis and treatment of disease. The Update also introduces an innovative system that follows up with patients after they go home from hospital. In this Issue: Medical Device Regulation In Canada: A Primer M...